Sponsor or institution
Clinical trials and research at Jonsson Comprehensive Cancer Center
As of November 12, 2026, Find a Trial lists 56 clinical trials run by Jonsson Comprehensive Cancer Center that are recruiting, in United States. By phase: Phase 2 (16), Phase 1/2 (6), Phase 1 (6), Early Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 56Clinical trials
- 1Country
Newest trials
All recruiting trials (56)
-
AB801 with chemotherapy and immunotherapy for cholangiocarcinoma and pancreatic cancer
This phase 1 study tests whether AB801 can be given safely with chemotherapy and immunotherapy in adults with border-line resectable, locally advanced, or metastatic cholangiocarcinoma or pancreatic cancer.
-
Triple-target radiosurgery for cancer pain using pituitary and thalamic neuromodulation
This study tests whether focused brain radiosurgery to the pituitary and specific thalamic regions can reduce pain in adults with cancer that’s not controlled by opioids or other treatments.
-
Focal HDR-Brachytherapy for Prostate Cancer
This trial tests using targeted high-dose-rate brachytherapy to treat prostate cancer patients and see if it provides local control with fewer side effects.
-
Using advanced MRI to image the tumor immune environment in glioblastoma
This project will test whether three advanced MRI methods (CEST, DR-CSI, and ferumoxytol-enhanced MRI) can noninvasively measure immune cells and proteins around glioblastoma tumors in adults preparing for surgery.
-
Individually Tailored, Supervised, Remote Exercise to Improve Function in Stage I-III Gastroesophageal Cancer Survivors
This trial tests a personalized, supervised home-based exercise program to see if it can improve physical function for adults who have completed treatment for early-stage gastroesophageal cancer.
-
Advanced MRI to distinguish recurrent brain tumor from radiation necrosis
This trial tests whether advanced MRI scans (DR-CSI and sodium imaging) can tell if people with metastatic brain tumors have tumor recurrence or treatment-related radiation necrosis.
-
Telisotuzumab vedotin combined with osimertinib for progressive, incurable non-small cell lung cancer
This trial tests whether adding the antibody-drug telisotuzumab vedotin to ongoing osimertinib can shrink tumors or slow growth in adults with progressive, incurable non-small cell lung cancer who have EGFR mutations.
-
Virtual reality versus calming music to reduce anxiety and pain during breast biopsies
This trial will see if a VR mindful meditation app or calming music helps women undergoing breast biopsies feel less anxious and in less pain than standard care.
-
Radiation tailored to protect the blood vessels and nerves that support erections
This trial tests a tailored five‑session high‑precision radiation approach to better protect the nerves and blood vessels that help with erections in men getting radiation for localized prostate cancer.
-
Image-guided adaptive stereotactic body radiation therapy for localized prostate cancer
This trial tests whether daily, real-time adaptive image-guided SBRT causes fewer urinary and other side effects than standard non-adaptive SBRT for men with localized prostate cancer.
-
Dapagliflozin before surgery for stage IA lung adenocarcinoma
This trial tests if taking dapagliflozin for 30 days before surgery is safe for adults with stage IA lung adenocarcinoma.
-
Imlunestrant and Abemaciclib for ER+ Breast Cancer with Minimal Residual Disease
This Phase 2 trial tests whether taking imlunestrant and abemaciclib together can help people with ER-positive breast cancer who still have detectable cancer after initial treatment.
-
Flotufolastat F18 PET/CT to find residual or recurrent prostate cancer after focal therapy
This test will see if flotufolastat F18 PET/CT can find prostate cancer that remains or comes back in men after focal therapy.
-
New PSMA PET/CT (flotufolastat F-18) compared with MRI to find prostate cancer
We are testing whether a PSMA PET/CT scan using flotufolastat F-18 can better guide targeted prostate biopsies in men with prostate cancer who have a suspicious MRI lesion (PI-RADS 3-5).
-
Alpha- versus beta-emitting PSMA therapy plus targeted body radiation for recurrent oligometastatic prostate cancer
This tests whether adding either an alpha-emitting PSMA drug (225Ac-PSMA-617) or a beta-emitting PSMA drug (177Lu-PSMA-617) to precise stereotactic body radiotherapy helps control recurrent oligometastatic prostate cancer.
-
ERAS-801 for operable or recurrent EGFR-altered IDH-wildtype Grade IV glioblastoma or astrocytoma
This trial tests ERAS-801, a brain-penetrant EGFR blocker, to see if it is safe and changes tumor metabolism in adults with resectable or recurrent IDH-wildtype Grade IV glioblastoma or astrocytoma that have EGFR amplification or mutation.
-
Post-prostatectomy SBRT with MRI/CT adaptive guidance to reduce urinary and bowel side effects
This registry will try MRI- or CT-guided stereotactic body radiotherapy (SBRT), sometimes using on-table adaptive planning, for men after prostatectomy who have adverse pathology or a rising PSA.
-
Ivonescimab therapy for thymic carcinoma
This trial tests whether ivonescimab can help adults with incurable, measurable thymic carcinoma who have had prior systemic therapy or cannot/will not have other treatments.
-
Screening mammograms with or without AI assistance for breast cancer detection
This trial will try using an FDA-cleared AI tool to help radiologists read screening mammograms for adults to see if it finds more cancers and reduces unnecessary callbacks.
-
Duvelisib plus venetoclax for relapsed or refractory peripheral T‑cell lymphoma
This trial tests whether combining duvelisib and venetoclax can help people with relapsed or refractory peripheral T‑cell lymphoma.
-
Imaging brain tumors using a targeted radioimmunoconjugate and PET scans
This study is testing a new imaging method using a special drug to see if it can help identify immune cells in patients with brain tumors before they have surgery.
-
Personalized radiation therapy for palliative treatment of head and neck cancer
This study is testing a new way to give radiation therapy for people with head and neck cancer who can't have regular treatments, to see if it helps control tumors better and reduce side effects.
-
Primary Care–GI Connect to improve colonoscopy follow-up after an abnormal FIT
This trial tests whether a clinic-wide Primary Care–GI Connect program helps patients at community health centers get colonoscopies within six months after an abnormal fecal immunochemical test (FIT).
-
External and internal radiation plus chemotherapy and immunotherapy for Stage IVB cervical cancer
This trial will try adding external beam radiation and brachytherapy to chemotherapy (cisplatin and paclitaxel) plus immunotherapy (pembrolizumab and bevacizumab) to see if it is safe and helps people with newly diagnosed Stage IVB cervical cancer.
-
Hypofractionated radiation therapy for endometrial and cervical cancers
This study is testing a new way of giving radiation therapy in larger doses over 5 days to see if it helps people who have had surgery for endometrial or cervical cancer feel better while making treatment easier.
-
New imaging method for detecting recurrent kidney cancer after surgery
This study is testing a new imaging method to see if it can better detect kidney cancer returning after surgery compared to the usual imaging techniques.
-
MRI and CT-guided radiation therapy for abdominopelvic sarcomas
This study tests if using MRI and CT scans to guide radiation therapy can help people with abdominopelvic sarcomas by targeting tumors more accurately while protecting healthy tissue.
-
Yttrium-90 treatment for early stage kidney cancer
This study is testing if a new treatment using tiny glass beads with radiation can help people with early stage kidney cancer by shrinking their tumors and improving their quality of life.
-
Improving colonoscopy follow-up for patients with high risk colon polyps
This study is testing whether better reminders and support for scheduling can help patients with high risk colon polyps get their follow-up colonoscopies done on time to lower their chances of developing colorectal cancer.
-
Re-treatment with a radioactive drug for advanced prostate cancer
This study is testing if giving a radioactive drug again can help men with advanced prostate cancer who did well on it before feel better and live longer.
-
Fluoxetine treatment to modify immune cells in colorectal cancer patients before surgery
This study is testing if taking fluoxetine for 10 days can change the immune cells in colorectal cancer patients before their surgery to see if it helps slow down tumor growth.
-
Flexible dosing of 177Lu-PSMA-617 for advanced prostate cancer treatment
This study is testing if a flexible schedule for a prostate cancer treatment can help men with advanced cancer live longer and feel better compared to the usual fixed schedule.
-
Using fisetin and exercise to prevent frailty in breast cancer survivors
This study is testing whether taking fisetin, a natural supplement, along with exercise can help prevent frailty in postmenopausal breast cancer survivors who have had chemotherapy.
-
Using MRI to understand brain tumor biology in patients with glioblastoma
This study is testing if MRI scans can help doctors understand brain tumors in patients with glioblastoma to see who might benefit from a specific treatment.
-
Hormone therapy and targeted radiation for prostate cancer treatment
This study is testing if combining a hormone therapy that blocks testosterone with targeted radiation can help men with prostate cancer see better results and improve their quality of life.
-
Using organoids to predict chemotherapy response in osteosarcoma
This study is trying to see how well different chemotherapy drugs work on osteosarcoma by testing them on tiny lab-grown versions of the tumors.
-
Investigating a new imaging technique for measuring glycolysis in glioblastoma tumors
This study is testing a new imaging method to see if it can help doctors measure how energy is used in glioblastoma tumors and find hidden cancer cells that are hard to see.
-
Using advocates to boost lung cancer screening rates
This study is testing if having advocates and support can help more people get screened for lung cancer by addressing their concerns and encouraging them to share information with others.
-
Combining pembrolizumab and enfortumab vedotin for treating high-risk upper tract urothelial cancer before and after surgery
This study tests whether combining two cancer treatments, pembrolizumab and enfortumab vedotin, can help people with high-risk upper tract urothelial cancer before and after surgery.
-
Combining zimberelimab and quemliclustat with chemotherapy for advanced pancreatic cancer
This study is testing if a new combination of zimberelimab and quemliclustat with chemotherapy can help people with advanced pancreatic cancer live longer and have better treatment outcomes.
-
Using fisetin to enhance physical function in breast cancer survivors
This study is testing if fisetin, a natural compound from strawberries, can help improve physical function and overall well-being in postmenopausal women who have had chemotherapy for breast cancer.
-
Using image-guided biopsies to understand resistance in advanced prostate cancer treatment
This study is testing how advanced imaging can help doctors understand why some men with hard-to-treat prostate cancer don't respond to a specific therapy, so they can find better treatment options.
-
Using acalabrutinib to prevent relapse in patients with large B-cell lymphoma
This study is testing if the drug acalabrutinib can help prevent cancer from coming back in patients with large B-cell lymphoma who are at high risk after treatment.
-
Combining high dose-rate brachytherapy and stereotactic body radiotherapy for prostate cancer treatment
This study is testing whether combining two types of radiation therapy can improve treatment outcomes for men with prostate cancer.
-
Exploring the use of a new imaging agent in prostate cancer surgery
This study is testing a new imaging agent to see if it can help doctors find cancerous lymph nodes during prostate cancer surgery.
-
Improving prostate cancer classification using MRI and AI
This study is testing whether using advanced MRI scans and artificial intelligence can help doctors better identify and classify prostate cancer.
-
Developing blood tests for diagnosing thyroid cancer
This study is testing a new blood test to help doctors tell if thyroid nodules are cancerous or not, using samples from patients with suspicious nodules or thyroid cancer.
-
Short course radiation therapy combined with chemotherapy for stage II-III rectal cancer
This study is testing a new treatment plan that combines short radiation therapy with chemotherapy to see if it helps people with stage II-III rectal cancer feel better and have fewer problems after treatment.
-
Treatment for early-stage HER2 low, hormone receptor positive breast cancer
This study is testing whether a new treatment combining trastuzumab deruxtecan and anastrozole can help people with early-stage HER2 low, hormone receptor positive breast cancer do better than just using trastuzumab deruxtecan alone.
-
Using abemaciclib to treat recurrent ovarian or endometrial cancer
This study is testing if the drug abemaciclib can help people with recurrent ovarian or endometrial cancer stay cancer-free for at least 16 weeks.
-
Using an iPhone app to help adolescents and young adults lose weight after stem cell transplant
This study is testing whether an iPhone app and coaching can help young people lose weight after they've had a stem cell transplant.
-
Investigating brain health in breast cancer survivors undergoing hormone therapy
This study is trying to see how hormone therapy affects brain function in breast cancer survivors, especially looking at how menopause plays a role.
-
Using pembrolizumab to treat leukoplakia
This study is testing if the drug pembrolizumab can help people with leukoplakia and related conditions get better.
-
5-day radiation therapy before surgery for soft tissue sarcomas
This study is testing if a shorter, stronger course of radiation therapy before surgery can help people with recurring soft tissue sarcomas do better and have fewer side effects.
-
Analyzing genetic mutations in cancer patients' blood and saliva
This study is testing whether looking at genetic changes in blood and saliva from cancer patients can help us understand their cancer risk and how well they respond to treatments.
-
Monitoring low-risk prostate cancer without immediate treatment
This study looks at how men with low-risk prostate cancer can be monitored over time without immediate treatment to understand how the disease progresses and how to best manage it.
Quick answers
How many clinical trials run by Jonsson Comprehensive Cancer Center are recruiting right now?
56, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 16, Phase 1/2: 6, Phase 1: 6, Early Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.